Why did NanoViricides (NNVC), ReWalk (RWLK) stocks skyrocket Tuesday?

3 min read | September 21, 2021 03:26 PM PDT | By Sanjeeb Baruah

Highlights

  • NanoViricides, Inc. (AMEX: NNVC) was up 65.45% at 3:18 pm ET, with a trading volume of 89,899,376.
  • ReWalk Robotics Ltd. (RWLK) rose 93.46% at 3:18 pm ET, with a share volume of 264,762,923.
  • NanoViricides stock rose 114.29%, and ReWalk Robotics stock jumped 73.86% YTD.

Stocks of NanoViricides, Inc. (AMEX: NNVC) and ReWalk Robotics Ltd. (NASDAQ:RWLK) skyrocketed by 65.45% and 93.46%, respectively, at 3:18 pm ET on Tuesday.

The NNVC stock was priced at US$6.2704, while RWLK traded at US$2.515 at the time.

NanoViricides, Inc.

The Shelton, Connecticut-based NanoViricides is a nano-biopharmaceutical company.

Its trading volume was 89,899,376 at 3:19 pm, ET. Its 30-day average volume is 1,322,884.00.

NNVC develops therapeutics for viral infections. The company launched its IPO in 2004.

The stock has been declining since September 14 when its trading volume was 33,589,170 and closing price was US$4.83. Tuesday’s rally was its first major jump since.

Also Read: Five blue-chip stocks to watch that have high price-to-earnings ratio

The stock’s 52-week highest and lowest prices were US$8.71 and US$2.85, respectively.

On Sep 14, the company said that it completed the licensing process for drug development and commercialization from TheraCour Pharma, Inc. NNVC’s pre-clinical work for two drug candidates is nearly complete, and the company is set to study these drugs in humans.

It did not earn any revenue in the March quarter of 2021. The net loss in the period was US$2.1 million against US$8.1 million in the same quarter a year ago. The cash and equivalents rose to US$22.9 million on March 31, 2021, from US$13.99 million on June 30, 2020.

Its market capitalization is US$78 million. The stock had closed at US$3.79 on Sep 20.

Also Read: Buy cheap, be a winner, says El Salvador’s Bukele as Bitcoin prices dip

Two trending healthcare stocks on Tuesday: NanoViricides (NNVC) and ReWalk Robotics (RWLK).

Also Read: 7 stocks worth exploring amid the buzz over commercial space voyages

ReWalk Robotics Ltd.

ReWalk is a medical device company based in Yokneam Ilit, Israel. The company offers the ReWalk system that helps wheelchair-bound patients to stand and walk again.

Its trading volume was 264,762,923 at 3:19 pm ET. The 30-day average volume is 379,578.00.

The company went public in 2014. The stock’s 52-week highest and lowest prices were US$6.00 and US$1.00, respectively.

Also Read: Top five mid-cap retail stocks with more than 100% YTD gain

There was no apparent reason for the stock’s sudden rally on Tuesday.

Its revenue for the June quarters of 2021 and 2020 were US$1.44 million and US$ 1.67 million, respectively. The net loss was US$3.14 million in the June quarter of 2021 compared to US$2.86 million in the same period of 2020. The cash and equivalents were US$64.2 million on June 30, 2021, compared to US$20.35 million on December 31, 2020.

Its market capitalization is US$108.6 million. The stock closed at US$1.3 on Sep 20.

Also Read: Top stocks to watch out this week

Bottomline

The NYSE Healthcare Index (NYP.ID) gave a 12.61% return YTD. The health sector has seen significant growth this year buoyed by speedy drug development and approval, especially for covid vaccines. The NanoViricides stock rose 114.29% YTD, while ReWalk stock rose 73.86% YTD. However, investors must evaluate the companies carefully before investing in stocks.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Limited, Company No. 12643132 (Kalkine Media, we or us) and is available for personal and non-commercial use only. Kalkine Media is an appointed representative of Kalkine Limited, who is authorized and regulated by the FCA (FRN: 579414). The non-personalised advice given by Kalkine Media through its Content does not in any way endorse or recommend individuals, investment products or services suitable for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a qualified financial planner and/or adviser. No liability is accepted by Kalkine Media or Kalkine Limited and/or any of its employees/officers, for any investment loss, or any other loss or detriment experienced by you for any investment decision, whether consequent to, or in any way related to this Content, the provision of which is a regulated activity. Kalkine Media does not intend to exclude any liability which is not permitted to be excluded under applicable law or regulation. Some of the Content on this website may be sponsored/non-sponsored, as applicable. However, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music/video that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music or video used in the Content unless stated otherwise. The images/music/video that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.


Sponsored Articles


Investing Ideas

Previous Next